Press Releases

May 2014

Full two-year data from the Mimics Study

February 2014

2-Year MIMICS Data Confirm Long-term Patency Protection With BioMimics 3D

October 2013

MIMICS Emerging Data Suggest Patency Protective Effect

May 2013

3D Helical Stent Twelve Month Data Suggest Correlation between Stented Vessel Curvature and Primary Patency

May 2013

Novel 3D Stent Demonstrates Safety and Efficacy at Nine Months in Treatment of PAD

March 2013

Veryan to Participate in Major European Medtech Conference

January 2012

Novel 3D Stent Demonstrates Safety and Efficacy at Nine Months in Treatment of PAD

November 2012

Veryan Receives CE Mark Approval for BioMimics 3D™ Stent

October 2012

Novel 3D Stent Demonstrates Safety and Efficacy in Treatment of PAD

July 2012

Veryan Appoints Two Industry Veterans as Non-Executive Directors

June 2012

Veryan appoints Nick Yeo as COO

March 2012

Veryan announces completion of enrolment in the Mimics study

October 2011

Veryan closes £5.0m funding round to develop novel BioMimics 3D stent technology and complete the MIMICS pivotal study.

March 2010

Veryan Closes £3.6m Funding Round to Develop Novel BioMimics 3D Stent Technology and Announces the Commencement of First-in Human Studies Press Release

July 2010

Veryan Announces commencement of the Randomised Phase of the Mimics Study